MY01 is a state-of-the-art medical device geared towards aiding in the detection of Compartment Syndrome (CS); a limb-threatening muscle condition which occurs within 48 hours following a trauma. Currently ACS is diagnosed based on subjective and unreliable outcomes like pain (known as 6 P’s), which when present cannot confirm the diagnosis in time for effective intervention. This leads to increased complications (muscle necrosis/amputation) and costs the US healthcare system more than $2.25 B annually. MY01 is capitalizing on a proven correlation between sustained increase in Intramuscular pressures and ACS for objective, early diagnosis. MY01 operationalizes muscular pressure monitoring into a simple, accurate single-use device.
MY01. The simple solution to a dangerous problem.
Engineered by NXTSENS
Location: Canada, Montreal (06), Montreal
Member count: 11-50
Total raised: $12.5M
Founded date: 2015
Investors 1
| Date | Name | Website |
| - | CTS | ctssante.c... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 12.04.2023 | - | $12.5M | - | finsmes.co... |
Mentions in press and media 4
| Date | Title | Description | Category | Author | Source |
| 12.04.2023 | MY01 raise... | - | - | - | betakit.co... |
| 11.04.2023 | MY01 Raise... | MY01, a Montreal, Canada-based... | Canada | - | finsmes.co... |
| 06.05.2021 | MY01 Inc. ... | MY01 provides the necessary ... | - | - | prnewswire... |
| 12.06.2019 | Eight Cana... | Eight Canadian healthtech comp... | - | - | betakit.co... |